(RAND) Rand Capital - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7521852076
RAND: Equity, Venture Capital, Debt, Stocks, Private Business Funding
Rand Capital Corporation (NASDAQ:RAND) is a business development company (BDC) that specializes in subordinated debt with warrants or preferred equity and venture capital investments. The firm focuses on capital growth and lower middle market investments within private equity and targets early to late-stage private businesses in the venture capital space. It avoids investments in the real estate sector, prioritizing instead industries such as software, professional services, manufacturing, consumer goods, healthcare, automotive, and public stocks. Geographically, the company prefers to invest in businesses operating in the East or Midwest regions of the U.S.
Typically, Rand Capital invests between $0.75 million and $5 million, with an initial target size of $1.5 million. It seeks companies with over $2 million in revenue or those generating between $1.5 million and $5 million in EBITDA. The firm prefers to hold a minority stake in its portfolio companies and often takes a Board seat to guide growth. Investments are generally held for up to five years, aligning with its strategy to support growth-stage businesses.
From a technical perspective, RANDs stock has shown recent weakness, trading below its 20-day SMA of 25.13 at a last price of 22.37. The 50-day SMA is 22.29, and the 200-day SMA is 15.71, indicating a potential sideways trend in the near term. The ATR of 1.40 suggests moderate volatility. On the fundamental side, the company has a market cap of $66.54 million, a P/E ratio of 5.17, and a P/B ratio of 0.94, indicating it is trading near book value. The P/S ratio of 7.97 and an RoE of 18.26 highlight its profitability relative to its revenue.
Exchange: NASDAQ
Type: common stock
Country Origin: United States
GICS Sub Industry: Asset Management & Custody Banks
Last Price: 22.37
SMA 20: 25.13
SMA 50: 22.29
SMA 200: 15.71
ATR: 1.40
P/E: 5.17
P/E Forward: 0.00
P/B: 0.94
P/S: 7.97
RoE: 18.26
Additional Sources for RAND Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
RAND Stock Overview
Market Cap in USD | 57m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 1995-08-18 |
RAND Stock Ratings
Growth 5y | 53.2% |
Fundamental | 42.6% |
Dividend | 57.8% |
Rel. Strength | 44.6 |
Analysts | - |
Fair Price Momentum | 25.01 USD |
Fair Price DCF | 119.29 USD |
RAND Dividends
Dividend Yield 12m | 29.62% |
Yield on Cost 5y | 44.38% |
Annual Growth 5y | 3.45% |
Payout Consistency | 16.1% |
RAND Growth Ratios
Growth Correlation 3m | 11.3% |
Growth Correlation 12m | 88.9% |
Growth Correlation 5y | 57.8% |
CAGR 5y | 15.28% |
CAGR/Max DD 5y | 0.27 |
Sharpe Ratio 12m | 0.50 |
Alpha | 72.74 |
Beta | 0.352 |
Volatility | 59.93% |
Current Volume | 3.5k |
Average Volume 20d | 15.5k |
As of April 01, 2025, the stock is trading at USD 18.77 with a total of 3,538 shares traded.
Over the past week, the price has changed by -1.26%, over one month by -15.39%, over three months by -1.32% and over the past year by +74.60%.
Partly, yes. Based on ValueRay Fundamental Analyses, Rand Capital (NASDAQ:RAND) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 42.60 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RAND as of April 2025 is 25.01. This means that RAND is currently undervalued and has a potential upside of +33.24% (Margin of Safety).
Rand Capital has no consensus analysts rating.
According to ValueRays Forecast Model, RAND Rand Capital will be worth about 27.2 in April 2026. The stock is currently trading at 18.77. This means that the stock has a potential upside of +45.13%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 27.2 | 45.1% |